Reported Reactions

Devices › Device types

FDA product code DZE · class 2 · Dental

Implant, endosseous, root-form: medical device reports filed with FDA

3,924,241 reports carry this product code, 1993–2026; 30 brands with a page.

3,924,241
reports with this product code
15% of all MAUDE reports
771,057
reports, 12 months to August 2026
767,516 in the 12 months before
0.8%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code DZE is FDA's classification for "Implant, endosseous, root-form" (dental panel), a class 2 device. 3,924,241 medical device reports carry this product code, 15% of the MAUDE database, from January 1993 to August 2026.

771,057 reports arrived in the 12 months to August 2026, close to the 767,516 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.2%) and malfunction (0.8%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Biohorizons Dental Implant58,73200%0%
BioHorizons Inc.57,00425,5360%0%
NobelActive Internal RP 4.3x10mm49,0989,5280%1%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%0%
NobelParallel CC RP 4.3x10mm44,2699,3180%0.6%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%0%
Unknown Implant39,9321,4540%1.2%
NobelReplace CC RP 4.3x10mm35,9468,1660%0.8%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%0.4%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%1.3%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%0%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%0%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%0%
NobelActive Internal RP 4.3x13mm25,5563,7640%1.4%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%0%
NobelParallel CC RP 4.3x8.5mm23,8805,1500%0.5%
BLT ?4.1mm RC, SLActive? 8mm, TiZr, NTP23,1264,8320%0%
BLT ?4.8mm RC, SLActive? 10mm, TiZr, NTP23,0504,5020%0%
Camlog Screw-Line Implant Promote plus23,0271,7330%0%
NobelParallel CC RP 4.3x11.5mm22,5724,3850%0.8%
NobelReplace CC PMC RP 4.3x8mm21,8225,6880%0.2%
BLT ?4.1mm RC, SLA? 12mm, TiZr, Loxim21,3403,9050%0%
BLT ?3.3mm NC, SLActive? 12mm, TiZr, NTP21,1463,5300%0%
NobelActive Internal RP 5.0x10mm21,0563,5690%1.1%
BLT ?4.8mm RC, SLA? 10mm, TiZr, Loxim20,9474,2760%0%
BLT ?3.3mm NC, SLA? 12mm, TiZr, Loxim20,6893,8260%0%
BLT ?4.1mm RC, SLActive? 12mm, TiZr, NTP20,3333,2140%0%
BLT ?4.8mm RC, SLActive? 8mm, TiZr, NTP20,2454,5100%0%
NobelActive Internal RP 4.3x8.5mm19,7703,8520%0.8%
NobelReplace CC RP 5.0x10mm18,0334,3590%0.7%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Institut Straumann1,209,13330.8%
Nobel Biocare899,04022.9%
Nobel Biocare G Teborg488,70012.5%
Jjgc234,2766%
Dentsply Implants Manufacturing171,4904.4%
Nobel Biocare USA143,3313.7%
Mis Implants Technologies126,8573.2%
Altatec90,9842.3%
Dentsply Implants A Division Of Dentsply Ih82,8282.1%
Anthogyr63,0741.6%
Biohorizons Implant Systems58,0361.5%
Biohorizons57,2631.5%
Implant Direct Sybron Manufacturing31,8070.8%
S I N Implant System29,4150.7%
Neodent - Jjgc23,6460.6%

Reports by month, five years

057,587115,173Sep 2021: 36,891Oct 2021: 39,670Nov 2021: 43,969Dec 2021: 36,7752022Jan 2022: 39,586Feb 2022: 33,706Mar 2022: 39,960Apr 2022: 36,631May 2022: 40,717Jun 2022: 39,293Jul 2022: 39,142Aug 2022: 44,278Sep 2022: 36,467Oct 2022: 44,842Nov 2022: 44,301Dec 2022: 44,3012023Jan 2023: 38,591Feb 2023: 38,173Mar 2023: 45,964Apr 2023: 42,700May 2023: 47,843Jun 2023: 53,337Jul 2023: 46,767Aug 2023: 45,654Sep 2023: 41,703Oct 2023: 45,546Nov 2023: 47,816Dec 2023: 43,4912024Jan 2024: 46,687Feb 2024: 47,610Mar 2024: 47,261Apr 2024: 55,084May 2024: 53,132Jun 2024: 49,757Jul 2024: 56,153Aug 2024: 60,413Sep 2024: 64,850Oct 2024: 67,920Nov 2024: 72,684Dec 2024: 75,5512025Jan 2025: 65,491Feb 2025: 55,438Mar 2025: 60,574Apr 2025: 28,827May 2025: 11,225Jun 2025: 81,922Jul 2025: 115,173Aug 2025: 67,861Sep 2025: 62,709Oct 2025: 62,405Nov 2025: 62,179Dec 2025: 72,0312026Jan 2026: 61,307Feb 2026: 63,796Mar 2026: 63,073Apr 2026: 63,582May 2026: 61,267Jun 2026: 65,803Jul 2026: 73,305Aug 2026: 59,600

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%44
Injury99.2%3,893,457
Malfunction0.8%30,044
Other0%597
Not given0%99

Who filed

Manufacturer report77.7%3,049,747
Voluntary report0%820
User facility report0%0
Distributor report22.3%873,665
Not given0%9

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Failure to osseointegrate2,465,58962.8%
Loss of osseointegration880,75222.4%
Osseointegration problem300,4817.7%
Fracturea broken bone63,5531.6%
Difficult to insertthe device was hard to insert14,1780.4%
Patient device interaction problem11,5880.3%
Insufficient device problem information6,7870.2%
Migrationthe device moved from where it was placed5,7830.1%
Separation failure5,0540.1%
Positioning failure4,2880.1%
Malposition of device3,1490.1%
Premature separation2,6170.1%
Material deformation2,3410.1%
Explanted2,1470.1%
Positioning problem2,0480.1%
Mechanical problema mechanical problem2,0300.1%
Loosening of implant not related to bone-ingrowth1,9780.1%
Unintended movement1,3460%
Activation, positioning or separation problem1,2840%
Device markings/labelling problema problem with the device markings or label1,2320%

Questions about implant, endosseous, root-form reports

What is product code DZE?

FDA's classification code for "Implant, endosseous, root-form", class 2, reviewed by the dental panel. Every device report carries the product code of the device involved.

How many reports carry this code?

3,924,241 reports through August 2026, 771,057 of them in the latest 12 months.

Which brands appear most often?

Biohorizons Dental Implant (58,732), BioHorizons Inc. (57,004), NobelActive Internal RP 4.3x10mm (49,098), BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim (45,650) and NobelParallel CC RP 4.3x10mm (44,269). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.